Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease by Varenhorst Christoph, James Stefan, Erlinge David, Brandt John T, Braun Oscar O, Man Michael, Siegbahn Agneta, Walker Joseph, Wallentin Lars, Winters Kenneth J, Close Sandra L in European heart journal (2009).

[PMID: 19429918] PubMed


Discussed In Paper


Variant Annotations

Sign in to see variant annotations.

Rx Annotations

No dosing information annotated.